首页 > 最新文献

American journal of surgery最新文献

英文 中文
The case for structural reform in medical student research access. 医学生研究机会结构改革的案例。
IF 2.7 3区 医学 Q1 SURGERY Pub Date : 2025-12-26 DOI: 10.1016/j.amjsurg.2025.116811
Tamara Kabbani, Anthony N Eze, Jacob A Greenberg, Lisa McElroy
{"title":"The case for structural reform in medical student research access.","authors":"Tamara Kabbani, Anthony N Eze, Jacob A Greenberg, Lisa McElroy","doi":"10.1016/j.amjsurg.2025.116811","DOIUrl":"https://doi.org/10.1016/j.amjsurg.2025.116811","url":null,"abstract":"","PeriodicalId":7771,"journal":{"name":"American journal of surgery","volume":" ","pages":"116811"},"PeriodicalIF":2.7,"publicationDate":"2025-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145888837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigating racial/ethnic disparities in opioid use among patients undergoing gastrointestinal cancer surgery 调查胃肠癌手术患者阿片类药物使用的种族差异。
IF 2.7 3区 医学 Q1 SURGERY Pub Date : 2025-12-26 DOI: 10.1016/j.amjsurg.2025.116799
Shahzaib Zindani , Zayed Rashid , Selamawit Woldesenbet , Mujtaba Khalil , Timothy M. Pawlik

Introduction

We sought to investigate racial/ethnic disparities in opioid prescribing patterns among patients undergoing gastrointestinal (GI) cancer surgery.

Methods

Patients who underwent surgery for GI cancer (2016–2023) were identified using the EPIC Cosmos database. Multivariate analyses were conducted to assess differences in opioid prescription patterns postoperatively.

Results

168,220 individuals underwent GI cancer surgery (esophagus: 2.5 %; stomach: 4.1 %, pancreas: 9.7 %; hepatobiliary: 6.4 %; colorectal: 77.3 %); 52.9 % were male, 86.0 % were White with median age of 72 years (IQR: 62–80). Black patients were younger (68 years [IQR: 60–76] vs. 72 years [IQR: 63–81]) and had a lower Charlson Comorbidity Index score (>2) (66.2 % vs. 68.5 %) compared with White patients (both p < 0.001). On multivariable analysis, Black patients had similar odds of receiving opioids as White patients (OR: 1.01, 95 % CI: 0.95–1.08).

Conclusion

No race-based differences were noted in the use of opioid prescriptions, duration of prescriptions, or mode of opioid administration following GI surgery.
前言:我们试图调查在接受胃肠道(GI)癌症手术的患者中阿片类药物处方模式的种族/民族差异。方法:使用EPIC Cosmos数据库对2016-2023年接受GI癌手术的患者进行识别。进行多变量分析以评估术后阿片类药物处方模式的差异。结果:168,220例患者接受了胃肠道肿瘤手术(食道2.5%,胃4.1%,胰腺9.7%,肝胆6.4%,结直肠77.3%);52.9%为男性,86.0%为白人,中位年龄72岁(IQR: 62 ~ 80)。黑人患者较白人患者年轻(68岁[IQR: 60-76]对72岁[IQR: 63-81]), Charlson合并症指数评分(>2)较白人患者低(66.2%对68.5%)(p均< 0.001)。在多变量分析中,黑人患者与白人患者接受阿片类药物的几率相似(OR: 1.01, 95% CI: 0.95-1.08)。结论:在胃肠道手术后阿片类药物处方的使用、处方持续时间或阿片类药物给药方式方面没有种族差异。
{"title":"Investigating racial/ethnic disparities in opioid use among patients undergoing gastrointestinal cancer surgery","authors":"Shahzaib Zindani ,&nbsp;Zayed Rashid ,&nbsp;Selamawit Woldesenbet ,&nbsp;Mujtaba Khalil ,&nbsp;Timothy M. Pawlik","doi":"10.1016/j.amjsurg.2025.116799","DOIUrl":"10.1016/j.amjsurg.2025.116799","url":null,"abstract":"<div><h3>Introduction</h3><div>We sought to investigate racial/ethnic disparities in opioid prescribing patterns among patients undergoing gastrointestinal (GI) cancer surgery.</div></div><div><h3>Methods</h3><div>Patients who underwent surgery for GI cancer (2016–2023) were identified using the EPIC Cosmos database. Multivariate analyses were conducted to assess differences in opioid prescription patterns postoperatively.</div></div><div><h3>Results</h3><div>168,220 individuals underwent GI cancer surgery (esophagus: 2.5 %; stomach: 4.1 %, pancreas: 9.7 %; hepatobiliary: 6.4 %; colorectal: 77.3 %); 52.9 % were male, 86.0 % were White with median age of 72 years (IQR: 62–80). Black patients were younger (68 years [IQR: 60–76] vs. 72 years [IQR: 63–81]) and had a lower Charlson Comorbidity Index score (&gt;2) (66.2 % vs. 68.5 %) compared with White patients (both p &lt; 0.001). On multivariable analysis, Black patients had similar odds of receiving opioids as White patients (OR: 1.01, 95 % CI: 0.95–1.08).</div></div><div><h3>Conclusion</h3><div>No race-based differences were noted in the use of opioid prescriptions, duration of prescriptions, or mode of opioid administration following GI surgery.</div></div>","PeriodicalId":7771,"journal":{"name":"American journal of surgery","volume":"253 ","pages":"Article 116799"},"PeriodicalIF":2.7,"publicationDate":"2025-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145916607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current urgent and emergent management of acute sigmoid diverticulitis … has the LADIES trial impacted change in surgical management at a single institution? 目前急性乙状结肠憩室炎的紧急和紧急治疗…LADIES试验是否影响了单一机构手术治疗的改变?
IF 2.7 3区 医学 Q1 SURGERY Pub Date : 2025-12-24 DOI: 10.1016/j.amjsurg.2025.116797
Nicholas Stevens, Raisa Gao-Gibbons, Clayton Wyland, Kayla Flewelling, Theresa McGoff, Austin Brubaker, Laurence E. McCahill

Introduction

For perforated sigmoid diverticulitis, the “gold standard” has traditionally been the Hartmann's Procedure (HP). The LADIES trial published in 2019 suggested that primary anastomosis (PA) is safe. Our study aims to evaluate whether the LADIES trial has influenced the surgical management of perforated diverticulitis at our institution.

Methods

Retrospective cohort study of patients undergoing urgent or emergent colectomy for perforated diverticulitis, divided into Group 1 (2013–2019) and Group 2 (post LADIES Trial, 2020–2024). Inclusion criteria was similar to the LADIES trial and included patients 85 years or younger, not immunocompromised, and without preoperative vasopressor requirements.

Results

There were 88 patients total, 41 patients in Group 1 and 47 in Group 2. No significant difference was noted in procedure performed, though there was an upwards trend for performing PA (19.5 % vs 36.2 %, p = 0.084) and creation of protective ileostomy (7.3 % vs 19.2 %, p = 0.129) in Group2.

Conclusion

After publication in 2019, our institution demonstrated limited adoption of the LADIES trial for surgical management of perforated diverticulitis. Further study is required to better delineate surgeon continued reluctance for PA in this setting.
对于乙状结肠穿孔性憩室炎,传统的“金标准”是哈特曼手术(HP)。2019年发表的LADIES试验表明,初级吻合(PA)是安全的。我们的研究旨在评估LADIES试验是否影响了我们机构穿孔性憩室炎的手术治疗。方法回顾性队列研究,对穿孔性憩室炎患者进行紧急或急诊结肠切除术,分为1组(2013-2019)和2组(LADIES试验后,2020-2024)。纳入标准与LADIES试验相似,纳入年龄在85岁或以下、无免疫功能低下、术前无血管加压药物需求的患者。结果共88例患者,其中1组41例,2组47例。虽然在第二组中进行PA (19.5% vs 36.2%, p = 0.084)和建立保护性回肠造口(7.3% vs 19.2%, p = 0.129)的比例呈上升趋势,但所执行的手术没有显著差异。在2019年发表后,我们的机构证明了在穿孔性憩室炎的手术治疗中有限地采用了LADIES试验。需要进一步的研究来更好地描述外科医生在这种情况下对PA的持续不情愿。
{"title":"Current urgent and emergent management of acute sigmoid diverticulitis … has the LADIES trial impacted change in surgical management at a single institution?","authors":"Nicholas Stevens,&nbsp;Raisa Gao-Gibbons,&nbsp;Clayton Wyland,&nbsp;Kayla Flewelling,&nbsp;Theresa McGoff,&nbsp;Austin Brubaker,&nbsp;Laurence E. McCahill","doi":"10.1016/j.amjsurg.2025.116797","DOIUrl":"10.1016/j.amjsurg.2025.116797","url":null,"abstract":"<div><h3>Introduction</h3><div>For perforated sigmoid diverticulitis, the “gold standard” has traditionally been the Hartmann's Procedure (HP). The LADIES trial published in 2019 suggested that primary anastomosis (PA) is safe. Our study aims to evaluate whether the LADIES trial has influenced the surgical management of perforated diverticulitis at our institution.</div></div><div><h3>Methods</h3><div>Retrospective cohort study of patients undergoing urgent or emergent colectomy for perforated diverticulitis, divided into Group 1 (2013–2019) and Group 2 (post LADIES Trial, 2020–2024). Inclusion criteria was similar to the LADIES trial and included patients 85 years or younger, not immunocompromised, and without preoperative vasopressor requirements.</div></div><div><h3>Results</h3><div>There were 88 patients total, 41 patients in Group 1 and 47 in Group 2. No significant difference was noted in procedure performed, though there was an upwards trend for performing PA (19.5 % vs 36.2 %, p = 0.084) and creation of protective ileostomy (7.3 % vs 19.2 %, p = 0.129) in Group2.</div></div><div><h3>Conclusion</h3><div>After publication in 2019, our institution demonstrated limited adoption of the LADIES trial for surgical management of perforated diverticulitis. Further study is required to better delineate surgeon continued reluctance for PA in this setting.</div></div>","PeriodicalId":7771,"journal":{"name":"American journal of surgery","volume":"253 ","pages":"Article 116797"},"PeriodicalIF":2.7,"publicationDate":"2025-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145882038","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Surgeon's Daughter. 外科医生的女儿。
IF 2.7 3区 医学 Q1 SURGERY Pub Date : 2025-12-24 DOI: 10.1016/j.amjsurg.2025.116800
Rebecca Tuttle
{"title":"A Surgeon's Daughter.","authors":"Rebecca Tuttle","doi":"10.1016/j.amjsurg.2025.116800","DOIUrl":"https://doi.org/10.1016/j.amjsurg.2025.116800","url":null,"abstract":"","PeriodicalId":7771,"journal":{"name":"American journal of surgery","volume":" ","pages":"116800"},"PeriodicalIF":2.7,"publicationDate":"2025-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145877387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrated psychosocial, sleep, and nutritional support improves postoperative recovery, immune modulation, and survival after curative resection for low rectal cancer: A randomized controlled trial. 综合心理社会、睡眠和营养支持可改善低位直肠癌根治性切除术后的术后恢复、免疫调节和生存率:一项随机对照试验。
IF 2.7 3区 医学 Q1 SURGERY Pub Date : 2025-12-24 DOI: 10.1016/j.amjsurg.2025.116795
Gang Wang, Shengjie Pan

Background: Patients undergoing low rectal cancer resection often experience psychological distress, sleep disturbance, nutritional decline, and functional impairment. Evidence for comprehensive supportive interventions is limited.

Methods: In this single-center RCT (n = 188), patients were randomized 1:1 to an integrative psychosocial-sleep-nutrition program or ERAS-based standard care. Outcomes included psychological distress (BDI-II, BAI), sleep quality (PSQI), anorectal (LARS) and sexual function (IIEF-5/FSFI), postoperative inflammatory markers, recovery, and 2-year survival.

Results: At 24 months, intervention patients showed greater reductions in BDI-II (-5.2), BAI (-3.8), and PSQI (-2.9), lower major LARS prevalence (28.7 % vs 46.2 %), and higher IIEF-5/FSFI scores. Postoperative CRP, IL-6, and TNF-α were lower (p < 0.001). Two-year DFS and OS were 90.3 % vs 79.2 % (p = 0.028) and 93.6 % vs 82.5 % (p = 0.019), respectively.

Conclusions: Multimodal psychosocial, sleep, and nutritional support improves psychological, functional, immunologic, and survival outcomes after low rectal cancer surgery.

背景:低位直肠癌切除术患者常出现心理困扰、睡眠障碍、营养下降和功能障碍。综合支持性干预措施的证据有限。方法:在这项单中心随机对照试验(n = 188)中,患者按1:1的比例随机分为综合心理-社会-睡眠-营养计划或基于erass的标准治疗。结果包括心理困扰(BDI-II, BAI)、睡眠质量(PSQI)、肛肠(LARS)和性功能(IIEF-5/FSFI)、术后炎症标志物、恢复情况和2年生存率。结果:在24个月时,干预患者的BDI-II(-5.2)、BAI(-3.8)和PSQI(-2.9)下降幅度更大,主要LARS患病率更低(28.7% vs 46.2%), IIEF-5/FSFI评分更高。术后CRP、IL-6、TNF-α降低(p < 0.001)。2年DFS和OS分别为90.3% vs 79.2% (p = 0.028)和93.6% vs 82.5% (p = 0.019)。结论:多模式的心理社会、睡眠和营养支持改善低位直肠癌手术后的心理、功能、免疫和生存结果。
{"title":"Integrated psychosocial, sleep, and nutritional support improves postoperative recovery, immune modulation, and survival after curative resection for low rectal cancer: A randomized controlled trial.","authors":"Gang Wang, Shengjie Pan","doi":"10.1016/j.amjsurg.2025.116795","DOIUrl":"https://doi.org/10.1016/j.amjsurg.2025.116795","url":null,"abstract":"<p><strong>Background: </strong>Patients undergoing low rectal cancer resection often experience psychological distress, sleep disturbance, nutritional decline, and functional impairment. Evidence for comprehensive supportive interventions is limited.</p><p><strong>Methods: </strong>In this single-center RCT (n = 188), patients were randomized 1:1 to an integrative psychosocial-sleep-nutrition program or ERAS-based standard care. Outcomes included psychological distress (BDI-II, BAI), sleep quality (PSQI), anorectal (LARS) and sexual function (IIEF-5/FSFI), postoperative inflammatory markers, recovery, and 2-year survival.</p><p><strong>Results: </strong>At 24 months, intervention patients showed greater reductions in BDI-II (-5.2), BAI (-3.8), and PSQI (-2.9), lower major LARS prevalence (28.7 % vs 46.2 %), and higher IIEF-5/FSFI scores. Postoperative CRP, IL-6, and TNF-α were lower (p < 0.001). Two-year DFS and OS were 90.3 % vs 79.2 % (p = 0.028) and 93.6 % vs 82.5 % (p = 0.019), respectively.</p><p><strong>Conclusions: </strong>Multimodal psychosocial, sleep, and nutritional support improves psychological, functional, immunologic, and survival outcomes after low rectal cancer surgery.</p>","PeriodicalId":7771,"journal":{"name":"American journal of surgery","volume":" ","pages":"116795"},"PeriodicalIF":2.7,"publicationDate":"2025-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145877429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hyperphosphatemia as a biomarker for early renal failure after trauma and development of the risk-for-renal-replacement-after-trauma (R3T) score 高磷血症作为创伤后早期肾衰竭的生物标志物和创伤后肾替代风险(R3T)评分的发展。
IF 2.7 3区 医学 Q1 SURGERY Pub Date : 2025-12-23 DOI: 10.1016/j.amjsurg.2025.116796
Ryan D. Rosen , Meredith Hazelrigg , Amanda B. Dooley-Romero , Mitchell Rits , Samantha L. Tarras , Heather Dolman

Background

Hyperphosphatemia occurs after trauma due to severe tissue injury. As the kidneys excrete phosphate, we investigate the relationship between hyperphosphatemia and renal failure after trauma, while developing a tool to predict the need for renal replacement therapy (RRT).

Methods

A retrospective study evaluated trauma admissions to the ICU. The primary outcome was RRT initiation within 14 days. Independent predictors of RRT were derived to create the Risk-for-Renal-Replacement-after-Trauma (R3T) Score. The R3T was validated with receiver-operating-characteristic (ROC) curves.

Results

1619 patients were included; 54 (3.3 %) required RRT. Elevated serum phosphate was associated with increased risk for RRT. Seven independent predictors were included in the R3T, yielding an area under the ROC curve of 0.947.

Conclusions

Hyperphosphatemia was associated with increased risk for RRT, suggesting phosphate levels are an inexpensive biomarker for renal failure after trauma. The R3T Score shows promise in identifying those at highest risk for RRT.
背景:高磷血症发生在严重组织损伤后。由于肾脏分泌磷酸盐,我们研究了创伤后高磷血症与肾功能衰竭之间的关系,同时开发了一种预测肾脏替代治疗(RRT)需求的工具。方法:回顾性研究评估创伤入院ICU。主要终点是在14天内启动RRT。导出RRT的独立预测因子以创建创伤后肾置换风险(R3T)评分。采用受试者工作特征(ROC)曲线对R3T进行验证。结果:共纳入1619例患者;54例(3.3%)需要RRT。血清磷酸盐升高与RRT风险增加相关。R3T中包含7个独立预测因子,ROC曲线下面积为0.947。结论:高磷血症与RRT风险增加相关,表明磷酸盐水平是创伤后肾衰竭的廉价生物标志物。R3T评分在识别RRT风险最高的人群方面显示出希望。
{"title":"Hyperphosphatemia as a biomarker for early renal failure after trauma and development of the risk-for-renal-replacement-after-trauma (R3T) score","authors":"Ryan D. Rosen ,&nbsp;Meredith Hazelrigg ,&nbsp;Amanda B. Dooley-Romero ,&nbsp;Mitchell Rits ,&nbsp;Samantha L. Tarras ,&nbsp;Heather Dolman","doi":"10.1016/j.amjsurg.2025.116796","DOIUrl":"10.1016/j.amjsurg.2025.116796","url":null,"abstract":"<div><h3>Background</h3><div>Hyperphosphatemia occurs after trauma due to severe tissue injury. As the kidneys excrete phosphate, we investigate the relationship between hyperphosphatemia and renal failure after trauma, while developing a tool to predict the need for renal replacement therapy (RRT).</div></div><div><h3>Methods</h3><div>A retrospective study evaluated trauma admissions to the ICU. The primary outcome was RRT initiation within 14 days. Independent predictors of RRT were derived to create the Risk-for-Renal-Replacement-after-Trauma (R3T) Score. The R3T was validated with receiver-operating-characteristic (ROC) curves.</div></div><div><h3>Results</h3><div>1619 patients were included; 54 (3.3 %) required RRT. Elevated serum phosphate was associated with increased risk for RRT. Seven independent predictors were included in the R3T, yielding an area under the ROC curve of 0.947.</div></div><div><h3>Conclusions</h3><div>Hyperphosphatemia was associated with increased risk for RRT, suggesting phosphate levels are an inexpensive biomarker for renal failure after trauma. The R3T Score shows promise in identifying those at highest risk for RRT.</div></div>","PeriodicalId":7771,"journal":{"name":"American journal of surgery","volume":"253 ","pages":"Article 116796"},"PeriodicalIF":2.7,"publicationDate":"2025-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145877447","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Time is valuable, people are too: Making the most of mentorship, coaching, and sponsorship. 时间是宝贵的,人也是:充分利用指导、指导和赞助。
IF 2.7 3区 医学 Q1 SURGERY Pub Date : 2025-12-22 DOI: 10.1016/j.amjsurg.2025.116789
Marquise D Singleterry, Calista M Harbaugh
{"title":"Time is valuable, people are too: Making the most of mentorship, coaching, and sponsorship.","authors":"Marquise D Singleterry, Calista M Harbaugh","doi":"10.1016/j.amjsurg.2025.116789","DOIUrl":"https://doi.org/10.1016/j.amjsurg.2025.116789","url":null,"abstract":"","PeriodicalId":7771,"journal":{"name":"American journal of surgery","volume":" ","pages":"116789"},"PeriodicalIF":2.7,"publicationDate":"2025-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145848774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From the Editor – in – Chief 来自总编辑。
IF 2.7 3区 医学 Q1 SURGERY Pub Date : 2025-12-22 DOI: 10.1016/j.amjsurg.2025.116790
Herbert Chen (Editor-in-Chief)
{"title":"From the Editor – in – Chief","authors":"Herbert Chen (Editor-in-Chief)","doi":"10.1016/j.amjsurg.2025.116790","DOIUrl":"10.1016/j.amjsurg.2025.116790","url":null,"abstract":"","PeriodicalId":7771,"journal":{"name":"American journal of surgery","volume":"252 ","pages":"Article 116790"},"PeriodicalIF":2.7,"publicationDate":"2025-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145846521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Developing and refining the advanced urology boot camp: What we did, what worked, and what we learned. 发展和完善高级泌尿外科新兵训练营:我们做了什么,什么有效,我们学到了什么。
IF 2.7 3区 医学 Q1 SURGERY Pub Date : 2025-12-22 DOI: 10.1016/j.amjsurg.2025.116792
Isobel Burridge, Abigail Dixon, Stephanie Jennifer Symons, Sunjay Jain, Chandra Shekhar Biyani, Stephen R Payne
{"title":"Developing and refining the advanced urology boot camp: What we did, what worked, and what we learned.","authors":"Isobel Burridge, Abigail Dixon, Stephanie Jennifer Symons, Sunjay Jain, Chandra Shekhar Biyani, Stephen R Payne","doi":"10.1016/j.amjsurg.2025.116792","DOIUrl":"https://doi.org/10.1016/j.amjsurg.2025.116792","url":null,"abstract":"","PeriodicalId":7771,"journal":{"name":"American journal of surgery","volume":" ","pages":"116792"},"PeriodicalIF":2.7,"publicationDate":"2025-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145896080","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Why surgeons need the Sabbath. 为什么外科医生需要安息日。
IF 2.7 3区 医学 Q1 SURGERY Pub Date : 2025-12-22 DOI: 10.1016/j.amjsurg.2025.116791
Hima Bindu Thota, T Clark Howell, Kevin I Ig-Izevbekhai, Ryan M Antiel
{"title":"Why surgeons need the Sabbath.","authors":"Hima Bindu Thota, T Clark Howell, Kevin I Ig-Izevbekhai, Ryan M Antiel","doi":"10.1016/j.amjsurg.2025.116791","DOIUrl":"https://doi.org/10.1016/j.amjsurg.2025.116791","url":null,"abstract":"","PeriodicalId":7771,"journal":{"name":"American journal of surgery","volume":" ","pages":"116791"},"PeriodicalIF":2.7,"publicationDate":"2025-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145888757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
American journal of surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1